Medicine Grand Rounds: CAR-T Therapy for Autoimmune Disease: From Breakthrough to Bedside

Presented by Melissa Griffith, MD, RhMSUS, Associate Professor of Medicine in the Division of Rheumatology at CU Anschutz.

Join us in person! Bruce Schroffel Auditorium, University of Colorado Hospital, Anschutz Inpatient Pavilion 2, First Floor Conference Room – Lunch Provided
or via Zoom.

Learning Objectives:
At the conclusion of this activity, participants should be able to:

• Review basic science of car-t therapy
• Examine the need for cellular therapies in autoimmune disease (AID)
• Review the use and clinical application of CAR-T cell therapy in AID
• Examine the future directions of CAR therapy in AID

Credit Designation:

• The Colorado Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Colorado Medical Society designates this live activity for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Event Disclosures:

Speakers:
Melissa Griffith, MD, RhMSUS has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Bristol Myers Squibb - Research support for clinical trials - Relationship Has Not Ended
• SonomaBio - Research Support for clinical trial - Relationship Has Not Ended
• Astra Zeneca - Research Support for clinical trial - Relationship Has Not Ended
• Merck - Research Support for clinical trial - Relationship Has Not Ended
• Allogene - Research Support for clinical trial - Relationship Has Not Ended
• Gilead - Research Support for clinical trial - Relationship Ended

Any financial relationship that was found to be relevant has been mitigated.

Planners and other Administrative Support:

Jennifer Spicer, MD has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
 

Commercial Support:

This activity is not commercially supported.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and CU Anschutz Department of Medince. The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.